Clinical Trials Using Flutemetamol F 18

Clinical trials are research studies that involve people. The clinical trials on this list are studying Flutemetamol F 18. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Flutemetamol F 18 PET / CT in Visualizing Chemotherapy-Induced Cognitive Impairment in Patients with Stage I-IIIC Breast Cancer

    This phase II trial studies how well flutemetamol F 18 ([18F]Flutemetamol)-positron emission tomography (PET) / computed tomography (CT), [18F]fluoro-2-deoxy-D-glucose (FDG)-PET / CT, and magnetic resonance imaging (MRI) work in predicting chemotherapy-induced cognitive impairment (CICI) in patients with stage I-IIIC breast cancer. Diagnostic procedures, such as PET / CT, uses imaging drugs, called “radiotracers”, such as flutemetamol F 18 and fludeoxyglucose F 18, to look at the brain. Each radiotracer has a small amount of radioactivity, which allows the scanner to see where the tracer goes. PET scans with these radiotracers may help doctors see a more complete picture of the brain and how it may be impacted by chemotherapy and predict which people may be susceptible to this chemotherapy-induced cognitive impairment.
    Location: Huntsman Cancer Institute / University of Utah, Salt Lake City, Utah